Endovascular therapy improves left ventricular diastolic function in heart failure with preserved ejection fraction
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
Medscape11d
Finerenone Reduces T2D Onset by 25% in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...
Research reports improved outcomes with mineralocorticoid receptor antagonists across different types of heart failure
Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization ...
EurekAlert!19d
Finerenone improves outcomes in a common type of heart failure
There are limited treatment options for the large population of patients with heart failure (HF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF).  In the FINEARTS-HF trial, finerenone ...
Hosted on MSN29d
Weight loss drug's heart benefits extend to people with heart failure, study finds
The study compared the impact of semaglutide for people with two types of heart failure: preserved ejection fraction, where the heart pumps blood normally but is too stiff to fill properly, and ...
EurekAlert!19d
Improved outcomes with mineralocorticoid receptor antagonists across different types of heart failure
This meta-analysis investigated the effects of mineralocorticoid receptor antagonists (MRAs) using data from nearly 14,000 patients with heart failure (HF) from four trials.  MRAs reduced the risk of ...